Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-24

Clinical Trial Update: Low Dose Heparin Factorial Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on low dose heparin for radial artery occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low dose heparin (heparin)

Snippet

Sponsor: Tabba Heart Institute | Conditions: Radial Artery Occlusion | Phase 3 | Status: UNKNOWN